A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
Clinical trial NCT04822103 · COMPLETED
Trial details
- NCT number
- NCT04822103
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2021-10-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.